SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Barbara Jordan — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBarbara Jordan
Date of birth1936-02-21
IdentifiersMRN HR-ML030-SYN-TD; SSN (made up) 000-30-6852
Document date1980-08-17
AuthorEvangeline Moss, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Ms. Jordan is a 44-year-old professor with active primary progressive multiple sclerosis who comes for her yearly preventive visit seven weeks after her four-month review. She had her two ocrelizumab half-doses three months ago and has had no infections since. Her walking is unchanged: she uses her cane on campus and a rollator at home for longer distances. The summer heat makes her legs heavier by the afternoon; her cooling vest and moving her seminars to the morning have helped. She has had no falls; on one hot afternoon in July her legs gave way briefly at home and her rollator caught her. Her bladder is better on mirabegron. She is preparing for the autumn term and several speaking engagements, and her university has put the accommodations she asked for in place. She had her bone density scan this morning. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 44
Multiple sclerosisOcrelizumab started three months ago; walking unchanged; no relapse
HeatLegs heavier in the afternoon heat; cooling vest helps
MoodPHQ-2 0

Health risk assessment. Completed by the patient on the clinic's online form before the visit and reviewed with her by Dr. Moss. [S]

DomainFinding
Self-rated healthGood
PsychosocialEngaged in her teaching and public work; good supports of her choosing; low stress apart from the term's start
Substance useNo tobacco; occasional alcohol within low-risk limits; no drug use
Physical activityHome exercise program from physical therapy most days; pool exercise twice a week in cool water
NutritionRegular meals; dairy at most meals for calcium; takes vitamin D3
SleepSeven hours; up once a night at most
Falls and home safetyNo falls this year; one near-fall in the July heat; grab bars and a shower seat installed; no loose rugs
DrivingDrives safely by her account; no hand-control need at present
WorkAccessible room, chair and lectern, and reserved parking in place
Activities of daily livingIndependent; tires by late afternoon
Seat belt and smoke alarmsAlways wears a seat belt; smoke alarms tested

Review of Systems

SystemResultFinding
ConstitutionalPositiveFatigue by late afternoon, worse in the heat; no fever or weight change
EyesNegativeNo blurred or double vision
Ears, nose, mouth, and throatNegativeNo hearing change or sore mouth
CardiovascularNegativeNo chest pain or leg swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeRegular bowels; no diarrhea
GenitourinaryNegativeUrgency improved; up once a night at most; no burning
BreastNegativeNo lump or nipple change
MusculoskeletalPositiveLeg stiffness in the mornings, eased by stretching
IntegumentaryNegativeNo rash or cold sores
NeurologicalPositiveLegs heavier in the heat, settling when she cools down; no new numbness or weakness lasting more than a day
PsychiatricNegativeMood steady; PHQ-2 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cholecalciferol (vitamin D3) 1954 units (50 mcg) oral capsule, one capsule dailyOne capsule dailyOral route1980-03-02activeS
Baclofen 5 mg oral tablet, one tablet three times a day, to be increased to 10 mg three times a day once toleratedOne tablet three times a dayOral route1980-03-16 to 1980-04-20completedS
Baclofen 10 mg oral tablet, one tablet three times a dayOne tablet three times a dayOral route1980-04-20activeS
Mirabegron 25 mg extended-release oral tablet, one tablet dailyOne tablet dailyOral route1980-03-16activeS
Ocrelizumab 300 mg intravenous infusion on day 1 and day 15, then 600 mg every 6 months, after methylprednisolone 100 mg intravenously, an antihistamine and acetaminophen, in the infusion center300 mg on day 1 and day 15 (given), then 600 mg every 6 monthsIntravenous route1980-05-04activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1980-08-17Body height173cmS
1980-08-17Body weight83.4kgS
1980-08-17Body mass index (BMI) [Ratio]27.9kg/m2S
1980-08-17Systolic blood pressure118mm[Hg]S
1980-08-17Diastolic blood pressure74mm[Hg]S
1980-08-17Heart rate74/minS
1980-08-17Respiratory rate16/minS
1980-08-17Body temperature36.7CelS
1980-08-17Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1980-08-17Hemoglobin A1c/Hemoglobin.total in Blood5.4%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
1980-08-17Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=199 mg/dLNormalS
1980-08-17Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation110mg/dL<=129 mg/dLNormalS
1980-08-17Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=50 mg/dLNormalS
1980-08-17Triglyceride [Mass/volume] in Serum or Plasma98mg/dL<=149 mg/dLNormalS
1980-08-17Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1980-08-17; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 83.4 kg; blood pressure 118/74
EyesPupils equal and reactive; no nystagmus
NeckNo thyroid enlargement or lymph nodes
BreastsClinical breast examination with a chaperone, at her choice: no masses, skin or nipple changes, or axillary nodes
CardiovascularRegular rhythm; no murmur; no leg swelling
RespiratoryClear
AbdomenSoft, non-tender
SkinNo rash or suspicious lesions
NeurologicalSpastic gait with the cane, as before; modified Ashworth 1+ in both legs; strength 4 out of 5 in the hip flexors; brisk leg reflexes
PsychiatricEngaged and precise

Problems

ProblemClinical statusVerificationCodeProvenance
Multiple sclerosis diagnosed elsewhere, by her account, with records of the original evaluation not available: slowly worsening walking over the past few years, leg stiffness, fatigue, urinary urgency and heat sensitivity; uses a cane; course to be classified after MRI of the brain and spineresolvedconfirmed G35.DS — Synthetic presenting picture at intake, superseded by the classified diagnosis at the consultation; the cane and a diagnosis around the time she left Congress are from public accounts.
Active primary progressive multiple sclerosis: gradual worsening of walking over more than a year without relapses, with brain lesions in periventricular, juxtacortical and infratentorial regions, three spinal cord lesions, and one gadolinium-enhancing lesion; fulfils the 1971 McDonald criteria for primary progressive disease; EDSS 6.0; synthetic modern detail linked to her publicly reported multiple sclerosisactiveconfirmed G35.B1S — Synthetic course, MRI findings and disability score; the disease itself and her use of a cane are from public accounts.
Spastic gait from multiple sclerosis, walking with a cane, with two near-falls and no falls in the past year; at risk of fallsactiveconfirmed R26.89S — Synthetic modern coding anchored to her documented cane.
Neurogenic bladder from multiple sclerosis: urgency and getting up twice at night, with a low post-void residualactiveconfirmed N31.9S — Synthetic; common in multiple sclerosis. No public source describes her bladder.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic laboratory finding at intake.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today118/74 mmHg
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 3 seven weeks ago
Unhealthy alcohol use screeningCompleted todayOccasional use within low-risk limits
Tobacco useCompleted todayNever
Breast cancer screeningOrderedMammogram every two years from 40; no previous mammogram on file; ordered today, with the ocrelizumab label's advice to follow standard screening
Cervical cancer screeningCompleted todayPrimary HPV test with a chaperone present, after she was told each step and agreed; result by phone
Colorectal cancer screeningNot indicatedBegins at 45, next year; she prefers a stool test
Diabetes and lipid screeningCompleted todayA1c 5.4%; total cholesterol 186, LDL 110, HDL 56, triglycerides 98 mg/dL; ten-year risk low, no statin
HIV and hepatitis C screeningUp to dateBoth negative at intake
Bone densityCompleted todayZ-scores -0.4 at the spine and -0.6 at the hip; done for reduced mobility and earlier steroid courses
Pneumococcal, zoster, Tdap and hepatitis B vaccinesUp to datePCV20, both recombinant zoster doses, Tdap and both hepatitis B doses given before ocrelizumab
Influenza and COVID-19 vaccines, this seasonDueAt the October review, at least two weeks before the next infusion
Live vaccinesNot indicatedNot recommended on ocrelizumab; varicella and measles immunity documented before treatment
Dental and eye examinationsDueDental review and an eye examination advised this year

Guideline basis: OCREVUS (ocrelizumab) injection, prescribing information (2026); Adult Immunization Schedule by Age (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018)

Follow-up: Mammogram this month; HPV result by phone. Re-baseline brain MRI and the eight-month review in October, with influenza and COVID-19 vaccines. Next preventive visit in one year. Next scheduled visit 1980-10-26: eight-month review before the first full ocrelizumab dose: re-baseline brain MRI, blood counts and immunoglobulins, seasonal vaccines, mobility and work. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment for any illness that could be reversed, wants to be told plainly what is happening, and wants to make her own decisions. She named a health care agent, recorded in the confidential part of the chart and not named here, and asked that information about her health be shared only with the people she names. She chose not to record other treatment preferences today. To be revisited yearly or after any serious illness. [S]